Prediction of breast cancer molecular subtypes using radiomics signatures of synthetic mammography from digital breast tomosynthesis

Abstract We aimed to predict molecular subtypes of breast cancer using radiomics signatures extracted from synthetic mammography reconstructed from digital breast tomosynthesis (DBT). A total of 365 patients with invasive breast cancer with three different molecular subtypes (luminal A + B, luminal;...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jinwoo Son, Si Eun Lee, Eun-Kyung Kim, Sungwon Kim
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/075f8ef6b92e451985836936ea3be9f4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:075f8ef6b92e451985836936ea3be9f4
record_format dspace
spelling oai:doaj.org-article:075f8ef6b92e451985836936ea3be9f42021-12-02T15:11:53ZPrediction of breast cancer molecular subtypes using radiomics signatures of synthetic mammography from digital breast tomosynthesis10.1038/s41598-020-78681-92045-2322https://doaj.org/article/075f8ef6b92e451985836936ea3be9f42020-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-78681-9https://doaj.org/toc/2045-2322Abstract We aimed to predict molecular subtypes of breast cancer using radiomics signatures extracted from synthetic mammography reconstructed from digital breast tomosynthesis (DBT). A total of 365 patients with invasive breast cancer with three different molecular subtypes (luminal A + B, luminal; HER2-positive, HER2; triple-negative, TN) were assigned to the training set and temporally independent validation cohort. A total of 129 radiomics features were extracted from synthetic mammograms. The radiomics signature was built using the elastic-net approach. Clinical features included patient age, lesion size and image features assessed by radiologists. In the validation cohort, the radiomics signature yielded an AUC of 0.838, 0.556, and 0.645 for the TN, HER2 and luminal subtypes, respectively. In a multivariate analysis, the radiomics signature was the only independent predictor of the molecular subtype. The combination of the radiomics signature and clinical features showed significantly higher AUC values than clinical features only for distinguishing the TN subtype. In conclusion, the radiomics signature showed high performance for distinguishing TN breast cancer. Radiomics signatures may serve as biomarkers for TN breast cancer and may help to determine the direction of treatment for these patients.Jinwoo SonSi Eun LeeEun-Kyung KimSungwon KimNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jinwoo Son
Si Eun Lee
Eun-Kyung Kim
Sungwon Kim
Prediction of breast cancer molecular subtypes using radiomics signatures of synthetic mammography from digital breast tomosynthesis
description Abstract We aimed to predict molecular subtypes of breast cancer using radiomics signatures extracted from synthetic mammography reconstructed from digital breast tomosynthesis (DBT). A total of 365 patients with invasive breast cancer with three different molecular subtypes (luminal A + B, luminal; HER2-positive, HER2; triple-negative, TN) were assigned to the training set and temporally independent validation cohort. A total of 129 radiomics features were extracted from synthetic mammograms. The radiomics signature was built using the elastic-net approach. Clinical features included patient age, lesion size and image features assessed by radiologists. In the validation cohort, the radiomics signature yielded an AUC of 0.838, 0.556, and 0.645 for the TN, HER2 and luminal subtypes, respectively. In a multivariate analysis, the radiomics signature was the only independent predictor of the molecular subtype. The combination of the radiomics signature and clinical features showed significantly higher AUC values than clinical features only for distinguishing the TN subtype. In conclusion, the radiomics signature showed high performance for distinguishing TN breast cancer. Radiomics signatures may serve as biomarkers for TN breast cancer and may help to determine the direction of treatment for these patients.
format article
author Jinwoo Son
Si Eun Lee
Eun-Kyung Kim
Sungwon Kim
author_facet Jinwoo Son
Si Eun Lee
Eun-Kyung Kim
Sungwon Kim
author_sort Jinwoo Son
title Prediction of breast cancer molecular subtypes using radiomics signatures of synthetic mammography from digital breast tomosynthesis
title_short Prediction of breast cancer molecular subtypes using radiomics signatures of synthetic mammography from digital breast tomosynthesis
title_full Prediction of breast cancer molecular subtypes using radiomics signatures of synthetic mammography from digital breast tomosynthesis
title_fullStr Prediction of breast cancer molecular subtypes using radiomics signatures of synthetic mammography from digital breast tomosynthesis
title_full_unstemmed Prediction of breast cancer molecular subtypes using radiomics signatures of synthetic mammography from digital breast tomosynthesis
title_sort prediction of breast cancer molecular subtypes using radiomics signatures of synthetic mammography from digital breast tomosynthesis
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/075f8ef6b92e451985836936ea3be9f4
work_keys_str_mv AT jinwooson predictionofbreastcancermolecularsubtypesusingradiomicssignaturesofsyntheticmammographyfromdigitalbreasttomosynthesis
AT sieunlee predictionofbreastcancermolecularsubtypesusingradiomicssignaturesofsyntheticmammographyfromdigitalbreasttomosynthesis
AT eunkyungkim predictionofbreastcancermolecularsubtypesusingradiomicssignaturesofsyntheticmammographyfromdigitalbreasttomosynthesis
AT sungwonkim predictionofbreastcancermolecularsubtypesusingradiomicssignaturesofsyntheticmammographyfromdigitalbreasttomosynthesis
_version_ 1718387610736394240